speb/financial-data huggingface dataset:
MED.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -889851.00
MED.DE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -11841307.00
MED.DE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 30489275.00
MED.DE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 13073740.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 54973025.00
MED.DE cash_flow (quarterly, 2025-06-30) — Sale Of Business: 2604281.00
MED.DE cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 5628.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Share Issued: 47500000.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 231864854.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 207429529.00
MED.DE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (quarterly, 2025-06-30) — Tax Provision: 2056354.00
MED.DE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.17
MED.DE cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -809597.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Total Assets: 902366648.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 296272293.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Total Debt: 455319907.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 232264822.00
MED.DE income_statement (quarterly, 2025-06-30) — Total Expenses: 181827658.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 670101826.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 602075085.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 505498354.00
MED.DE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 17127763.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 9582683.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 40046188.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Working Capital: 135688091.00
MED.DE income_statement (quarterly, 2025-09-30) — +Operating Expense: 145212082.00
MED.DE income_statement (quarterly, 2025-09-30) — +Total Revenue: 203128171.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 9038905.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 90560483.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 69932.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 534260.00
MED.DE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 100045778.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 326667485.00
MED.DE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -12166477.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 382379747.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 117292863.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 128215938.00
MED.DE cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
MED.DE cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 138787.00
MED.DE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -2554609.00
MED.DE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -864960.00
MED.DE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 17247085.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Common Stock: 47500000.00
MED.DE cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: 0.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 247645056.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 56826795.00
MED.DE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 31363127.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Current Assets: 317923003.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 27317007.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Current Debt: 1228217.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 28545224.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 164517537.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Current Provisions: 9478403.00
MED.DE cash_flow (quarterly, 2025-09-30) — Deferred Tax: 6106672.00
MED.DE cash_flow (quarterly, 2025-09-30) — Depreciation: 13142412.00
MED.DE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 13142412.00
MED.DE income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 13142412.00
MED.DE income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 13142412.00
MED.DE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 15394276.00
MED.DE income_statement (quarterly, 2025-09-30) — EBIT: 27017574.00
MED.DE income_statement (quarterly, 2025-09-30) — EBITDA: 40159986.00
MED.DE cash_flow (quarterly, 2025-09-30) — End Cash Position: 117292863.00
MED.DE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -12355673.00
MED.DE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 28026669.00
MED.DE cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -4375.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Goodwill: 16395079.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 24283538.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 529030429.00
MED.DE income_statement (quarterly, 2025-09-30) — Gross Profit: 171765044.00
MED.DE income_statement (quarterly, 2025-09-30) — Interest Expense: 5463669.00
MED.DE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 5463669.00
MED.DE income_statement (quarterly, 2025-09-30) — Interest Income: 464612.00
MED.DE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 464612.00
MED.DE cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -5517193.00
MED.DE cash_flow (quarterly, 2025-09-30) — Interest Received Cfo: 413049.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Inventory: 6895355.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 313041873.00
MED.DE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -10590388.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 534260.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Investmentsin Subsidiariesat Cost: 58822.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 101205267.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 355062740.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 64168600.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 419231340.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 58822.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 2344048.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 41710994.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Minority Interest: 456166.00
MED.DE income_statement (quarterly, 2025-09-30) — Minority Interests: -52957.00
MED.DE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 1567569.00
MED.DE income_statement (quarterly, 2025-09-30) — Net Income: 15394276.00
MED.DE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 15394276.00
MED.DE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 15447233.00
MED.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 15394276.00
MED.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 15394276.00
MED.DE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 15447233.00
MED.DE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 15447233.00
MED.DE cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -509558.00
MED.DE income_statement (quarterly, 2025-09-30) — Net Interest Income: -4999057.00
MED.DE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -4999057.00
MED.DE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -339674.00
MED.DE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Net PPE: 529030429.00
MED.DE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -11648399.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 223361518.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 9662968.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 36446392.00
MED.DE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 40159986.00
MED.DE income_statement (quarterly, 2025-09-30) — Normalized Income: 15394276.00
MED.DE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 40193146.00
MED.DE income_statement (quarterly, 2025-09-30) — Operating Income: 26552962.00
MED.DE income_statement (quarterly, 2025-09-30) — Operating Revenue: 203128171.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 7888459.00
MED.DE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 6499598.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 39951261.00
MED.DE income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 19351004.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Other Payable: 84781050.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Other Properties: 2619888.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Other Receivables: 87049169.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 10923075.00
MED.DE income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Payables: 107142757.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 5132126.00
MED.DE income_statement (quarterly, 2025-09-30) — Pretax Income: 21553905.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
MED.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -509558.00
MED.DE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -11656919.00
MED.DE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 31363127.00
MED.DE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 13142412.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 31681486.00
MED.DE cash_flow (quarterly, 2025-09-30) — Sale Of Business: 1567569.00
MED.DE cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 8520.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Share Issued: 47500000.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 247645056.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 223361518.00
MED.DE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (quarterly, 2025-09-30) — Tax Provision: 6106672.00
MED.DE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.28
MED.DE cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -546483.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Total Assets: 910591800.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 311813656.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Total Debt: 447776564.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 248101222.00
MED.DE income_statement (quarterly, 2025-09-30) — Total Expenses: 176575209.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 662490578.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 592668797.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 497973041.00
MED.DE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 26552962.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 13322802.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 39951261.00
MED.DE balance_sheet (quarterly, 2025-09-30) — Working Capital: 153405466.00
MED.DE income_statement (annual, 2025-12-31) — +Operating Expense: 609500000.00
MED.DE income_statement (quarterly, 2025-12-31) — +Operating Expense: 165873181.00
MED.DE income_statement (annual, 2025-12-31) — +Total Revenue: 784500000.00
MED.DE income_statement (quarterly, 2025-12-31) — +Total Revenue: 197572135.00
MED.DE balance_sheet (annual, 2025-12-31) — Accounts Payable: 16758337.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 16758337.00
MED.DE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 85871455.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 85871455.00
MED.DE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -611947000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -611947000.00
MED.DE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -4498000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -4498000.00
MED.DE income_statement (annual, 2025-12-31) — Amortization: 10600000.00
MED.DE balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 20972025.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 20972025.00
MED.DE balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 630928.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 630928.00
MED.DE income_statement (annual, 2025-12-31) — Basic Average Shares: 47500000.00
MED.DE income_statement (annual, 2025-12-31) — Basic EPS: 0.54
MED.DE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 107563091.00
MED.DE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 117292863.00
MED.DE balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 577615000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 577615000.00
MED.DE cash_flow (annual, 2025-12-31) — Capital Expenditure: -51424125.00
MED.DE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -15756461.00
MED.DE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 375960625.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 375960625.00
MED.DE balance_sheet (annual, 2025-12-31) — Capital Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 47500000.00
MED.DE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 72183731.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 72183731.00
MED.DE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 82355731.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 82355731.00
MED.DE cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1900000.00
MED.DE cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
MED.DE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -6789201.00
MED.DE cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 7785240.00
MED.DE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 2293109.00
MED.DE cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1174393.00
MED.DE cash_flow (annual, 2025-12-31) — Change In Working Capital: -10918728.00
MED.DE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 2172769.00
MED.DE cash_flow (annual, 2025-12-31) — Changes In Cash: -34672433.00
MED.DE cash_flow (quarterly, 2025-12-31) — Changes In Cash: -44402205.00
MED.DE balance_sheet (annual, 2025-12-31) — Common Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Common Stock: 47500000.00
MED.DE cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -1900000.00
MED.DE cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: 0.00
MED.DE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 248945667.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 248945667.00
MED.DE balance_sheet (annual, 2025-12-31) — Construction In Progress: 41260000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 41260000.00
MED.DE income_statement (annual, 2025-12-31) — Cost Of Revenue: 122500000.00
MED.DE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 28105480.00
MED.DE balance_sheet (annual, 2025-12-31) — Current Assets: 284107493.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Current Assets: 284107493.00
MED.DE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 27381148.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 27381148.00
MED.DE balance_sheet (annual, 2025-12-31) — Current Debt: 1115532.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Current Debt: 1115532.00
MED.DE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 28496680.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 28496680.00
MED.DE balance_sheet (annual, 2025-12-31) — Current Liabilities: 169337101.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 169337101.00
MED.DE balance_sheet (annual, 2025-12-31) — Current Provisions: 6031097.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Current Provisions: 6031097.00
MED.DE cash_flow (annual, 2025-12-31) — Deferred Tax: 9295351.00
MED.DE cash_flow (quarterly, 2025-12-31) — Deferred Tax: 1027580.00
MED.DE cash_flow (annual, 2025-12-31) — Depreciation: 60222174.00
MED.DE cash_flow (quarterly, 2025-12-31) — Depreciation: 21146513.00
MED.DE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 60222174.00
MED.DE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 21146513.00
MED.DE income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 60300000.00
MED.DE income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 21224339.00
MED.DE income_statement (annual, 2025-12-31) — Depreciation Income Statement: 49700000.00
MED.DE income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 10624339.00
MED.DE income_statement (annual, 2025-12-31) — Diluted Average Shares: 47500000.00
MED.DE income_statement (annual, 2025-12-31) — Diluted EPS: 0.54
MED.DE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 25486439.00
MED.DE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 377066.00
MED.DE income_statement (annual, 2025-12-31) — EBIT: 57258007.00
MED.DE income_statement (quarterly, 2025-12-31) — EBIT: 7029271.00
MED.DE income_statement (annual, 2025-12-31) — EBITDA: 117558007.00
MED.DE income_statement (quarterly, 2025-12-31) — EBITDA: 28253610.00
MED.DE cash_flow (annual, 2025-12-31) — End Cash Position: 72890658.00
MED.DE cash_flow (quarterly, 2025-12-31) — End Cash Position: 72890658.00
MED.DE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -99972970.00
MED.DE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -61982229.00
MED.DE cash_flow (annual, 2025-12-31) — Free Cash Flow: 51014072.00
MED.DE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 11046090.00
MED.DE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -107550.00
MED.DE cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -64693.00
MED.DE income_statement (annual, 2025-12-31) — General And Administrative Expense: 16500000.00
MED.DE balance_sheet (annual, 2025-12-31) — Goodwill: 8836000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Goodwill: 8836000.00
MED.DE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 17026865.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 17026865.00
MED.DE balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 90369000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 90369000.00
MED.DE balance_sheet (annual, 2025-12-31) — Gross PPE: 1114792000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1114792000.00
MED.DE income_statement (annual, 2025-12-31) — Gross Profit: 662000000.00
MED.DE income_statement (quarterly, 2025-12-31) — Gross Profit: 169466655.00
MED.DE income_statement (annual, 2025-12-31) — Interest Expense: 22060945.00
MED.DE income_statement (quarterly, 2025-12-31) — Interest Expense: 5417739.00
MED.DE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 22060945.00
MED.DE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 5417739.00
MED.DE income_statement (annual, 2025-12-31) — Interest Income: 1776263.00
MED.DE income_statement (quarterly, 2025-12-31) — Interest Income: 573903.00
MED.DE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1776263.00
MED.DE income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 573903.00
MED.DE cash_flow (annual, 2025-12-31) — Interest Paid Cff: -20966250.00
MED.DE cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -4932347.00
MED.DE cash_flow (annual, 2025-12-31) — Interest Received Cfo: 1696977.00
MED.DE cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: 549047.00
MED.DE balance_sheet (annual, 2025-12-31) — Inventory: 5453605.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Inventory: 5453605.00
MED.DE balance_sheet (annual, 2025-12-31) — Invested Capital: 263818229.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 263818229.00
MED.DE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -37137660.00
MED.DE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -9222527.00
MED.DE balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 630928.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 630928.00
MED.DE balance_sheet (annual, 2025-12-31) — Land And Improvements: 262110000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 262110000.00
MED.DE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 348579477.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 348579477.00
MED.DE balance_sheet (annual, 2025-12-31) — Long Term Debt: 13757030.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 13757030.00
MED.DE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 362336507.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 362336507.00
MED.DE balance_sheet (annual, 2025-12-31) — Long Term Provisions: 1186985.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 1186985.00
MED.DE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 233807000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 233807000.00
MED.DE balance_sheet (annual, 2025-12-31) — Minority Interest: 686971.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Minority Interest: 686971.00
MED.DE income_statement (annual, 2025-12-31) — Minority Interests: -415272.00
MED.DE income_statement (quarterly, 2025-12-31) — Minority Interests: -206886.00
MED.DE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
MED.DE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -7536742.00
MED.DE income_statement (annual, 2025-12-31) — Net Income: 25486439.00
MED.DE income_statement (quarterly, 2025-12-31) — Net Income: 377066.00
MED.DE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 25486439.00
MED.DE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 377066.00
MED.DE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 25901711.00
MED.DE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 583952.00
MED.DE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 25486439.00
MED.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 377066.00
MED.DE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 25486439.00
MED.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 377066.00
MED.DE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 25901711.00
MED.DE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 583952.00
MED.DE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 25901711.00
MED.DE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 583952.00
MED.DE cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -2998023.00
MED.DE cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -1136293.00
MED.DE income_statement (annual, 2025-12-31) — Net Interest Income: -20284682.00
MED.DE income_statement (quarterly, 2025-12-31) — Net Interest Income: -4843836.00
MED.DE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -98968.00
MED.DE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -20284682.00
MED.DE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -4843836.00
MED.DE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -51543191.00
MED.DE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -50524255.00
MED.DE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 14076619.00
MED.DE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 13956769.00
MED.DE balance_sheet (annual, 2025-12-31) — Net PPE: 502845000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Net PPE: 502845000.00
MED.DE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -48117288.00
MED.DE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -14407293.00
MED.DE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 231918802.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 231918802.00
MED.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 10570059.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 10570059.00
MED.DE balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 33226969.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 33226969.00
MED.DE income_statement (annual, 2025-12-31) — Normalized EBITDA: 117558007.00
MED.DE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 28253610.00
MED.DE income_statement (annual, 2025-12-31) — Normalized Income: 25486439.00
MED.DE income_statement (quarterly, 2025-12-31) — Normalized Income: 377066.00
MED.DE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 102438197.00
MED.DE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 26802551.00
MED.DE income_statement (annual, 2025-12-31) — Operating Income: 52500000.00
MED.DE income_statement (quarterly, 2025-12-31) — Operating Income: 3593474.00
MED.DE income_statement (annual, 2025-12-31) — Operating Revenue: 784500000.00
MED.DE income_statement (quarterly, 2025-12-31) — Operating Revenue: 197572135.00
MED.DE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (annual, 2025-12-31) — Other Current Assets: 139.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 139.00
MED.DE balance_sheet (annual, 2025-12-31) — Other Current Liabilities: -149.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: -149.00
MED.DE balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 8190865.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 8190865.00
MED.DE balance_sheet (annual, 2025-12-31) — Other Inventories: -395.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Other Inventories: -395.00
MED.DE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 18627492.00
MED.DE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1911145.00
MED.DE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 386.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 386.00
MED.DE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 23629044.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 23629044.00
MED.DE income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 800000.00
MED.DE income_statement (annual, 2025-12-31) — Other Operating Expenses: 50900000.00
MED.DE income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -3204233.00
MED.DE balance_sheet (annual, 2025-12-31) — Other Payable: 33449865.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Other Payable: 33449865.00
MED.DE balance_sheet (annual, 2025-12-31) — Other Receivables: 85905355.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 85905355.00
MED.DE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 10172000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 10172000.00
MED.DE income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.DE income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.DE balance_sheet (annual, 2025-12-31) — Payables: 70802636.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Payables: 70802636.00
MED.DE balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 41521000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 41521000.00
MED.DE balance_sheet (annual, 2025-12-31) — Prepaid Assets: 3549183.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3549183.00
MED.DE income_statement (annual, 2025-12-31) — Pretax Income: 35197062.00
MED.DE income_statement (quarterly, 2025-12-31) — Pretax Income: 1611532.00
MED.DE balance_sheet (annual, 2025-12-31) — Properties: 0.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MED.DE cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -2998023.00
MED.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -1136293.00
MED.DE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -98968.00
MED.DE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -48426102.00
MED.DE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -14620168.00
MED.DE balance_sheet (annual, 2025-12-31) — Raw Materials: 5454000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Raw Materials: 5454000.00
MED.DE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 122500000.00
MED.DE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 28105480.00
MED.DE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 60222174.00
MED.DE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 21146513.00
MED.DE income_statement (annual, 2025-12-31) — Rent And Landing Fees: 5100000.00
MED.DE income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 5100000.00
MED.DE balance_sheet (annual, 2025-12-31) — Retained Earnings: 32058552.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 32058552.00
MED.DE cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
MED.DE cash_flow (quarterly, 2025-12-31) — Sale Of Business: -7536742.00
MED.DE cash_flow (annual, 2025-12-31) — Sale Of PPE: 308814.00
MED.DE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 212875.00
MED.DE income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 2900000.00
MED.DE income_statement (annual, 2025-12-31) — Selling General And Administration: 19400000.00
MED.DE balance_sheet (annual, 2025-12-31) — Share Issued: 47500000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 47500000.00
MED.DE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 248945667.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 248945667.00
MED.DE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 231918802.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 231918802.00
MED.DE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (annual, 2025-12-31) — Tax Provision: 9295351.00
MED.DE income_statement (quarterly, 2025-12-31) — Tax Provision: 1027580.00
MED.DE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.26
MED.DE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
MED.DE cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -2279230.00
MED.DE cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -523762.00
MED.DE balance_sheet (annual, 2025-12-31) — Total Assets: 841252244.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 841252244.00
MED.DE balance_sheet (annual, 2025-12-31) — Total Capitalization: 262702697.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 262702697.00
MED.DE balance_sheet (annual, 2025-12-31) — Total Debt: 390833187.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 390833187.00
MED.DE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 249632638.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 249632638.00
MED.DE income_statement (annual, 2025-12-31) — Total Expenses: 732000000.00
MED.DE income_statement (quarterly, 2025-12-31) — Total Expenses: 193978661.00
MED.DE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 591619606.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 591619606.00
MED.DE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 557144751.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 557144751.00
MED.DE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 422282505.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 422282505.00
MED.DE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 55361894.00
MED.DE income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 6455368.00
MED.DE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 20594434.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 20594434.00
MED.DE balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 1903000.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 1903000.00
MED.DE balance_sheet (annual, 2025-12-31) — Working Capital: 114770392.00
MED.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: 114770392.00
MED.DE income_statement (quarterly, 2026-03-31) — +Operating Expense: 142589147.00
MED.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 186885887.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 5686867.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 88424592.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 20972025.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 612466.00
MED.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 50410986.00
MED.DE income_statement (quarterly, 2026-03-31) — Basic EPS: 0.07
MED.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 72890845.00
MED.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -7648656.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 369536688.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 78270444.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 152400612.00
MED.DE cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -4751027.00
MED.DE cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 5637089.00
MED.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 843458.00
MED.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 6086526.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 252473890.00
MED.DE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 29286580.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Current Assets: 290541098.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 27515620.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 27515620.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 167073100.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Current Provisions: 6153793.00
MED.DE cash_flow (quarterly, 2026-03-31) — Depreciation: 12956734.00
MED.DE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 12956734.00
MED.DE income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 12956734.00
MED.DE income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 12956734.00
MED.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 50410986.00
MED.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.07
MED.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 3528769.00
MED.DE income_statement (quarterly, 2026-03-31) — EBIT: 9603693.00
MED.DE income_statement (quarterly, 2026-03-31) — EBITDA: 22560427.00
MED.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 78977371.00
MED.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -11265642.00
MED.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 3553670.00
MED.DE cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -247707.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Goodwill: 8835610.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 16670016.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 498986108.00
MED.DE income_statement (quarterly, 2026-03-31) — Gross Profit: 157599307.00
MED.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 4875369.00
MED.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 4875369.00
MED.DE income_statement (quarterly, 2026-03-31) — Interest Income: 304999.00
MED.DE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 304999.00
MED.DE cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -4498139.00
MED.DE cash_flow (quarterly, 2026-03-31) — Interest Received Cfo: 304999.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Inventory: 5906632.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 252473890.00
MED.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 6149842.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 612466.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 342021068.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 342021068.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 325861.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Minority Interest: 700969.00
MED.DE income_statement (quarterly, 2026-03-31) — Minority Interests: -13998.00
MED.DE cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 13300414.00
MED.DE income_statement (quarterly, 2026-03-31) — Net Income: 3528769.00
MED.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 3528769.00
MED.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3542767.00
MED.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3528769.00
MED.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3528769.00
MED.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 9298694.00
MED.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3542767.00
MED.DE cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -290085.00
MED.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: -4570370.00
MED.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4570370.00
MED.DE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -343565.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 498986108.00
MED.DE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -6860487.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 235803874.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 11149301.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 33480280.00
MED.DE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 22560427.00
MED.DE income_statement (quarterly, 2026-03-31) — Normalized Income: 3528769.00
MED.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 11202326.00
MED.DE income_statement (quarterly, 2026-03-31) — Operating Income: 15010160.00
MED.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 186885887.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 6619730.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 91683974.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 7834406.00
MED.DE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -1305923.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 25477189.00
MED.DE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -5711466.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Other Properties: 498986108.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 16217507.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 74130168.00
MED.DE income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Payables: 12139434.00
MED.DE income_statement (quarterly, 2026-03-31) — Pretax Income: 4728324.00
MED.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -290085.00
MED.DE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -7358571.00
MED.DE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 29286580.00
MED.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 12956734.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 35586775.00
MED.DE cash_flow (quarterly, 2026-03-31) — Sale Of Business: 13300414.00
MED.DE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 498084.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 47500000.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 252473890.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 235803874.00
MED.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 1185557.00
MED.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
MED.DE cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -10647929.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 835903669.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 252473890.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Total Debt: 369536688.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 253174859.00
MED.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 171875727.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 582728810.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 545362571.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 415655710.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 6452567.00
MED.DE balance_sheet (quarterly, 2026-03-31) — Working Capital: 123467998.00
MED.SW cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -1.00
MED.SW cash_flow (annual, 2021-12-31) — Pension And Employee Benefit Expense: 679135.00
MED.SW income_statement (annual, 2022-12-31) — +Operating Expense: 151359000.00
MED.SW income_statement (annual, 2022-12-31) — +Total Revenue: 182824000.00
MED.SW balance_sheet (annual, 2022-12-31) — Accounts Payable: 9595000.00
MED.SW balance_sheet (annual, 2022-12-31) — Accounts Receivable: 39931000.00
MED.SW balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -79434000.00
MED.SW balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -1209000.00
MED.SW cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 1473000.00
MED.SW balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 1557000.00
MED.SW income_statement (annual, 2022-12-31) — Basic Average Shares: 11834473.00
MED.SW income_statement (annual, 2022-12-31) — Basic EPS: -0.49
MED.SW cash_flow (annual, 2022-12-31) — Beginning Cash Position: 82642000.00
MED.SW balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 54915000.00
MED.SW cash_flow (annual, 2022-12-31) — Capital Expenditure: -18794000.00
MED.SW balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 27030000.00
MED.SW balance_sheet (annual, 2022-12-31) — Capital Stock: 2371000.00
MED.SW balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 20605000.00
MED.SW balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 20605000.00
MED.SW cash_flow (annual, 2022-12-31) — Change In Inventory: -9036000.00
MED.SW cash_flow (annual, 2022-12-31) — Change In Payable: -2781000.00
MED.SW cash_flow (annual, 2022-12-31) — Change In Receivables: -7462000.00
MED.SW cash_flow (annual, 2022-12-31) — Change In Working Capital: -19279000.00
MED.SW cash_flow (annual, 2022-12-31) — Changes In Cash: -60737000.00
MED.SW balance_sheet (annual, 2022-12-31) — Common Stock: 2371000.00
MED.SW balance_sheet (annual, 2022-12-31) — Common Stock Equity: 237779000.00
MED.SW cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1882000.00
MED.SW income_statement (annual, 2022-12-31) — Cost Of Revenue: 33335000.00
MED.SW balance_sheet (annual, 2022-12-31) — Current Assets: 137881000.00
MED.SW balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 5158000.00
MED.SW balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5158000.00
MED.SW balance_sheet (annual, 2022-12-31) — Current Liabilities: 39526000.00
MED.SW balance_sheet (annual, 2022-12-31) — Current Provisions: 6070000.00
MED.SW cash_flow (annual, 2022-12-31) — Deferred Tax: -1362000.00
MED.SW cash_flow (annual, 2022-12-31) — Depreciation: 16639000.00
MED.SW cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 18112000.00
MED.SW income_statement (annual, 2022-12-31) — Diluted Average Shares: 11834473.00
MED.SW income_statement (annual, 2022-12-31) — Diluted EPS: -0.49
MED.SW income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -5783000.00